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Identification of cancer cells in the peritoneal cavity could influence therapy and outcome of gastric carcinoma patients. The objective
of this study was to evaluate the clinical impact of the real-time quantitative polymerase chain reaction-(PCR) based identification of
isolated tumour cells in the peritoneal lavage fluid of gastric carcinoma. The peritoneal lavage fluid of 116 patients with gastric cancer
was sampled at laparotomy. After RNA extraction and reverse transcription, real-time quantitative PCR was performed using the
primers and probes for carcinoembryonic antigen (CEA) and cytokeratin-20 (CK20). When either the CEA mRNA or CK20 mRNA level
of the sample was over the cutoff value, the sample was determined to be PCR-positive. Forty-six (40%) of the 116 patients were
PCR-positive and 30 (65%) of the 46 PCR-positive patients died as a result of recurrent peritoneal dissemination. The prognosis of
the 46 PCR-positive patients was significantly (Po0.001) worse than that of 70 PCR-negative patients. Furthermore, in 80 of the
cases with a curative R0 resection, 15 of the patients with PCR-positive findings had a significantly (Po0.001) poorer prognosis than
the 65 PCR-negative patients. The prognosis of the PCR-positive patients was significantly poorer than that of the PCR-negative
patients in the T3 (Po0.0001) and T4 (P¼0.048) subgroups. In a multivariate analysis of the 80 cases with a curative R0 resection,
the real-time quantitative RT–PCR (CEA and/or CK20) levels indicated that they were independent prognostic factors. The real-time
quantitative RT–PCR analysis of the CEA and/or CK20 transcripts in the peritoneal lavage fluid is useful for predicting the peritoneal
recurrence in patients who are undergoing a curative resection for gastric cancer.
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The prognosis of patients with early gastric cancer has been
improved in recent years. However, patients with an advanced
form of gastric carcinoma, especially a serosa-invading tumour
such as a T3 or T4 cancer, still have a poor prognosis (Martin et al,
2002; Tsuburaya et al, 2005). The detection of micrometastases
and disseminated cancer cells in patients with tumours who are
undergoing curative surgery is a challenging field in oncology
because the dissemination of neoplastic cells is the main reason for
distant relapse and cancer-related death (Timar et al, 2001).
Peritoneal dissemination is the most common type of recurrence
after surgery in these advanced cases and is one of the reasons for
their poor prognosis (Baba et al, 1989; Yoo et al, 2000). Peritoneal
dissemination may arise from the free cancer cells in the peritoneal
cavity exfoliated mainly from the serosal surface of the primary
tumour. Cancer identification of the tumour cells in the peritoneal
cavity could influence the therapy and the outcome of the patients
undergoing surgery for advanced gastric carcinoma.
Peritoneal lavage cytology at laparotomy has been a standard
method for the detection of free tumour cells and a useful
predictor of peritoneal recurrence in gastric cancer. However, by
the conventional cytology, patients with negative cancer cells have
occasionally developed recurrent peritoneal disease after surgery,
which thus resulted in a low sensitivity of the cytology (Boku et al,
1990; Abe et al, 1995; Schofield et al, 1997; de Manzoni et al, 2006).
Almost half of all patients with serosa-invading gastric carcinoma
experience peritoneal recurrence even after a curative surgical
resection (Martin et al, 2002; Tsuburaya et al, 2005). These patients
with recurrent peritoneal disease have already developed micro-
metastasis on the peritoneum at the time of surgery. Micro-
metastases are defined as single disseminated tumour cells or small
clusters of neoplastic cells, which can be occasionally detected
by conventional cytology (Singletary et al, 2003; Sobin, 2003).
Recently, the reverse transcriptase–polymerase chain reaction
(RT–PCR) technique has made it possible to detect only a few
cancer cells in the abdominal cavity and the technique is more
sensitive than with traditional peritoneal lavage cytology (Kodera
et al, 1998; Timar et al, 2002). The conventional RT–PCR used for
the detection of the proper band of tumour nucleotides on agarose
gel is sensitive, but does not always have a high specificity due to the
fact that false positives are sometimes obtained as a result of the
weak expression in non-cancerous cells, such as mesothelial cells
and lymphocytes (Kodera et al,1 9 9 8 ;S a k a k u r aet al,2 0 0 1 ) .T h e
real-time quantitative RT–PCR is a more specific and quantitative
method for the detection of tumour nucleotides by free cancer cells
in peritoneal washes (Nakanishi et al, 2000; Osaka et al,2 0 0 4 ) .T h e
objective of this study was to clarify the clinical impact of the real-
time quantitative RT–PCR-based identification of isolated tumour
cells in the peritoneal lavage fluid of gastric carcinoma.
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Patients
In this study, 124 patients with gastric cancer were enrolled. A
laparotomy and preoperative peritoneal lavage were performed on
all 124 patients who intended to undergo a gastrectomy in our
department. During the operation, the abdominal cavity was
thoroughly examined for tumour metastasis. When a potentially
curative resection was considered possible, a gastrectomy with a
D2 lymphadenectomy was performed. A palliative resection was
performed for the patients who were not treated with a curative
resection. A bypass operation was performed for patients who were
unable to receive a gastrectomy because of extensive invasion to
adjacent organs or extensive peritoneal dissemination. Five
patients were excluded who died as a result of liver metastasis
(three patients), lung metastasis (one patient), and bone metastasis
(one patient). Glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) mRNA was undetectable in the samples of three
patients. Next, the data from the remaining 116 patients
were analysed. Of the 116 patients with resectable cancer, 80
underwent a potentially curative R0 resection, 29 were treated with
a palliative resection, and the remaining seven patients were
considered unresectable and underwent bypass operations. As
negative controls, the peritoneal lavage specimens obtained from
10 of the patients with cholecystolithiasis for cholecystectomy were
used. Informed consent to participate in this study was obtained
from all of the patients before their surgery. The pathologic
diagnoses and classifications were made according to the TNM
staging system (Sobin, 2003) of the Union Internationale Contre le
Cancer (UICC). After the surgical resection, all patients underwent
a follow-up, with the median follow-up at analysis being 32 months
for all patients. The follow-up programme of post-operative
surveillance consisted of physical examination, blood chemistry
including CEA, computed tomography, and ultrasound performed
every 3 months to diagnose recurrent diseases.
Peritoneal lavage sample
Just after laparotomy, 100ml of normal saline was poured into the
Douglas’ pouch and then was left in the subphrenic space, and then
the peritoneal lavage fluid was collected from the cavity before a
surgical resection. Half of the peritoneal lavage fluid was examined
through conventional cytological methods with Papanicolaou
staining, and for the remaining half, the free cancer cells in the
abdominal cavity were detected by means of a molecular diagnosis,
as described below.
RNA extraction
The peritoneal lavage fluid was centrifuged at 2000r.p.m. for
10min to collect the intact cells and then dissolved in a TRIZOL
Reagent (Gibco, Gaithersburg, MD, USA). The mixture and 0.5ml
of chloroform in a 1.5ml tube was centrifuged at 12000r.p.m. for
15min. Next, the supernatant was transferred to a fresh tube, and
0.2ml propanol was added. The RNA was precipitated after
centrifugation at 12000r.p.m. for 10min, washed with 75%
ethanol, and diluted with DEPC-treated water. The purified RNA
was then quantified and assessed for purity by UV spectro-
photometry.
Reverse transcriptase–polymerase chain reaction
Complementary DNA (cDNA) was prepared from each sample
using oligo-(dT)15 primer and M-MLV Reverse Transcriptase (Life
Technologies, Rockville, MD, USA). RT reaction was performed
at 371C for 50min, followed by heating at 701C for 10min.
PCR amplification was performed using the following primer
sequences, For cytokeratin20 (CK20): forward 50-CTCTCCTCA
AAAAGGAGCATCAG-30; reverse 50-CAACCTCCACATTGACAGT
GTTG-30; Taqman probe FAM-CAGATGCTTGTGTAGGCCATC
GACTTCCT-TAMRA. For carcinoembryonic antigen (CEA): for-
ward 50-CAATAGGACCACAGTCACGACGAT-30, reverse 50-GGTT
GGAGTTGTTGCTGGTGAT-30; Taqman probe FAM-ACAGTC
TATGCAGAGCCACCCAAACCCTT-TAMRA. For GAPDH: forward
50-GAAGGTGAAGGTCGGAGTC-30, reverse 50-GAAGATGGTGAT
GGGATTTC-30, Taqman probe VIC-CAAGCTTCCCGTTCTCAG
CC-TAMRA. Real-time quantitative RT–PCR was carried out
using the ABI PRISM 7700 Sequence Detection system (Applied
Biosystems, Foster City, CA, USA) per the manufacturer’s protocol.
The total volume of the PCR was 50ml, containing 2ml of cDNA
template, 25ml TaqMan Universal PCR Master Mix (Applied
Biosystems), 0.1mM probe, and 0.3mM of each primer. The PCR
conditions were as follows: after incubation at 501C for 2min and
denaturing at 951C for 10min, 40 cycles of 15s at 951C, and 60s at
601C. The mRNA level of each gene was normalised by the internal
control GAPDH.
Standard curve
The gastric cancer cell line, OCUM-2M (Yashiro et al, 1995), was
used for the construction of a standard curve of CEA and CK20
expression. The cDNA from 1mg of RNA from the OCUM-2M cells
was diluted with normal monocytes at various ratios. The PCR
cycling conditions according to the manufacturer’s protocol were
40 cycles of 15s at 951C and 60s at 601C. The threshold cycle Ct
represents the fractional cycle number at which a significant
increase above the baseline signal was first detected. The log
starting copy number is plotted against the threshold cycle Ct. The
standard curves for CEA, CK20, and GAPDH were then con-
structed. According to the standard curve, the CEA and CK20
mRNA levels were calculated.
Statistical analysis
We used the w
2 test, Fisher’s exact test, or the Mann–Whitney
U-test to determine the significance of the differences between
the covariates. The survival durations were calculated using the
Kaplan–Meier method and were analysed by the log–rank test to
compare the cumulative survival durations in the patient groups.
The survival curve was calculated from the date of surgery. The
Cox proportional hazards model was used to compute the
univariate and multivariate hazards ratios for the study para-
meters. For all of the tests, a P-value of less than 0.05 was
considered to be statistically significant. The SPSS software
program (SPSS Japan, Tokyo, Japan) was used for the analyses.
RESULTS
Determination of cutoff values
Figure 1 shows the CEA/GAPDH mRNA ratios and the CK20/
GAPDH mRNA ratios according to the depth of the tumour
invasion. Each cutoff value was determined as the mean plus 2 s.d.
based on the quantified values of the control and the T1 samples.
The cutoff value of the CEA/GAPDH (Figure 1A) and CK20/GAPDH
(Figure 1B) levels were 2.490 10
 2 and 6.726 10
 3, respectively.
When the CEA or CK20 mRNA/GAPDH mRNA level of the sample
was above the cutoff value, the mRNA expression was considered
positive, and the sample was determined to be PCR-positive.
Correlation between clinicopathological factors and CEA
and/or CK20 expression in the peritoneal lavage fluid
All 116 patients were subjected to both a CEA and/or CK20
examination and a cytological examination. All of the peritoneal
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slavages from the control (n¼10) were negative for the quantitative
RT–PCR of CEA and/or CK20 expression. CEA was positive in
three (11%) of the 28 patients with T1 cancer and in 35 (40%) of
the 88 patients with T2, T3, or T4 cancer (Figure 1A). CK20 was
positive in three (11%) of the 28 patients with T1 cancer, and 31
(35%) of the 88 patients with T2, T3, or T4 cancer were CK20-
positive (Figure 1B). Sixty-four (73%) of the 88 patients with T2,
T3, or T4 cancer were cytology-negative, and 19 (30%) of the 64
cytology-negative patients with T2, T3, or T4 cancer died as a
result of peritoneal recurrence. In these 19 patients, CEA or CK20
was positive in 9 and 11, respectively (Figure 1). Table 1
summarises the correlation between the CEA and/or CK-20
expression of the peritoneal lavage fluid and the clinicopatholo-
gical parameters. The molecular diagnosis significantly correlated
with the T stage as the depth of tumour invasion (Po0.001),
peritoneal dissemination at operation (Po0.001), cytology
(Po0.001), stage (Po0.001), and lymph node disease (Po0.001).
In contrast, there was no statistically significant association
between CEA and/or CK20 and hepatic metastasis at operation,
tumour differentiation, venous invasion, or lymphatic invasion.
Recurrent peritoneal metastasis
Peritoneal recurrence was analysed in 116 patients. Table 2
summarises the correlation between peritoneal recurrence in these
116 cases and the results of the peritoneal lavage assays. Thirty-
eight (33%) of the 116 patients were positive for CEA mRNA and
34 (29%) of the 116 patients were positive for CK-20 mRNA. Forty-
six (40%) patients were positive for either marker and were thus
determined to be PCR-positive. The sensitivities and specificities
were calculated based on the diagnosis of peritoneal metastases
during the postoperative surveillance period. Death by recurrent
peritoneal metastasis was found in 37 (32%) of the 116 patients.
CEA or CK20 mRNA levels are helpful for the prediction of
peritoneal recurrence with a sensitivity of 72.7 or 54.6%, and a
specificity of 82.7 or 80.3%, respectively (Table 2). In Figure 1, the
closed circle and square show patients who died by peritoneal
recurrence. Peritoneal recurrence was frequently found in 34 of the
88 advanced gastric cancer (T2, T3, and T4 categories) patients,
while it was found in only three of the 28 early gastric cancer
(T1 category) patients. Meanwhile, the combination of CEA and/or
CK20 mRNA levels had a sensitivity of 86.4% and a specificity
of 81.5%.
Survival
The prognosis of all 116 patients with PCR-positive tumours was
significantly (Po0.001) worse than those with PCR-negative
tumours (Figure 2A). Moreover, in the 80 patients with a curative
R0 resection, the prognosis of the PCR-positive patients (n¼15)
was significantly (Po0.001) worse than those 65 patients who were
PCR-negative (Figure 2B). In addition, we analysed the prognostic
significance of the CEA and/or CK20 expression in the four
subgroups, T1, T2, T3, and T4 (Figure 3). The prognosis of the
patients with PCR-positive cancer was significantly poorer than
those with PCR-negative cancer in the T3 (Po0.0001; Figure 3A)
and T4 (P¼0.048; Figure 3B) subgroups, while no significant
difference in prognosis was found between the CEA and/or CK20
expression in the T1 and T2 subgroups (data not shown). In the
clinical stage, the prognosis of the PCR-positive cancer was
significantly poorer than the PCR-negative cancer in stage III
(P¼0.0004; Figure 3C) and stage IV (P¼0.035; Figure 3D), while
no significant difference in prognosis was found between the CEA
and/or CK20 expression in stages I and II (data not shown).
We evaluated prognostic markers in 80 patients of curative
R0 resection. According to a univariate analysis (Table 3), the
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Figure 1 Expression levels of CK20 and CEA mRNA. CEA/GAPDH mRNA ratios and CK20/GAPDH mRNA ratios were shown according to depth
of tumour invasion. The CEA mRNA and CK20 mRNA expression of the peritoneal lavage fluid of the control samples (n¼10), T1 (n¼28), T2 (n¼23), T3
(n¼52), and T4 (n¼13), were quantified by RT–PCR. The CEA/GAPDH mRNA ratios and CK20/GAPDH mRNA ratios were plotted according to T stage
of TNM classification. Each cutoff value was determined based on the mean plus 2 s.d. of the CEA/GAPDH mRNA ratios and CK20/GAPDH mRNA ratios
level in the peritoneal lavage fluid of the control and T1 samples. (A) The cutoff value of CEA/GAPDH was 2.490 10
 2. CEA was positive in 3 (11%) of the
28 patients with T1 cancer and in 35 (40%) of the 88 patients with T2, T3, or T4 cancer. (B) The cutoff value of CK20/GAPDH was 6.726 10
 3. CK20 was
positive in 3 (11%) of the 28 patients with T1 cancer, and 31 (35%) of the 88 patients with T2, T3, or T4 cancer were CK20-positive. Sixty-four (73%) of the
88 patients with T2, T3, or T4 cancer were cytology-negative, and 19 (30%) of the 64 cytology-negative patients with T2, T3, or T4 cancer died due to
peritoneal recurrence. In these 19 patients, CEA or CK20 was positive in 9 and 11, respectively. The open or closed circles show the cytology-negative
patients. The open or closed squares show the cytology-positive patients. The closed circle and closed square show patients who died by peritoneal
recurrence Owing to the TNM staging system of the Union Internationale Contre le Cancer.
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sRT–PCR (CEA and/or CK20), T stage, and stage were significantly
correlated with patient survival. In a multivariate analysis
(Table 4), the RT–PCR (CEA and/or CK20), and tumour depth
were found to be independent prognostic factors.
DISCUSSION
In patients with a curative R0 resection, the prognosis of the
patients with PCR-positive tumours was significantly worse than
those with PCR-negative tumours. Regarding overall survival, a
multivariate analysis showed that the current real-time quantita-
tive RT–PCR technique using CEA and/or CK20 was an
independent prognostic factor for the patients with a curative R0
resection. Moreover, the RT–PCR method was found to be useful
in T3 or T4 gastric cancer in which peritoneal dissemination is the
main cause of death after a surgical resection. These findings
suggest that the RT–PCR detection of the CEA and/or CK20
transcripts in the peritoneal lavage specimens has a prognostic
relevance in patients who are undergoing a curative resection for
T3 and T4 gastric cancer. Most of the current chemotherapy
regimens have failed to improve the survival of T3 and T4 gastric
cancer patients (Martin et al, 2002; Tsuburaya et al, 2005). The
RT–PCR assay of peritoneal lavage can be a reliable method for
the selection of patients for therapeutic chemotherapy.
Many markers, including CEA, CK20, CK19, MAGE, and MMP-7,
have previously been applied to detect micrometastases of gastric
cancer (Okami et al, 2000; Yonemura et al, 2001; Kodera et al,
2002; Lin et al, 2002; Matsuda et al, 2004; Arigami et al, 2006;
Horibe et al, 2007). Our preliminary study showed that the CK19
and MMP-7 mRNA were detected in the peritoneal lavage fluid
from the control benign disease, and that the MAGE-1 and MAGE-3
mRNA were occasionally undetectable in the cytology-positive
samples. Also, the CK19 mRNA was expressed in the normal
control tissues, and the presence of the pseudogenes of CK19
reportedly limits its value. Therefore, CK19, MAGE, and MMP-7
were not used as a diagnostic marker for the detection of
peritoneal micrometastasis in this study. In contrast, CEA has
been reported to be a reliable target for the detection of
disseminated gastric cancer cells, and is the most common marker
for detecting micrometastasis with RT–PCR (Kodera et al, 1998;
Nakanishi et al, 2000; Osaka et al, 2004). The quantitative RT–PCR
method using multiple markers reportedly improved the sensiti-
vity and specificity of the quantitative RT–PCR method (Guller
et al, 2002; Timar et al, 2002; Osaka et al, 2004; Fujita et al, 2006).
We therefore selected the combination of CEA and CK-20 as
diagnostic markers for predicting micrometastasis in patients with
gastric carcinoma in this study.
Some papers have reported the use of GAPDH mRNA as a
quantity marker to possibly not be necessary (Kodera et al, 2002;
Ito et al, 2005). However, GAPDH is considered to be necessary
because a specific genetic marker for gastric cancer has not yet
been found. We used the CEA/GAPDH ratio or CK20/GAPDH ratio
for a subsequent analysis in the present study. The cutoff value was
determined based on the mean plus 2 s.d. of the samples of the
benign disease and T1 gastric cancers, as well as those of the others
(Osaka et al, 2004; Oyama et al, 2004). The PCR methods resulted
in more false positives than other methods. The RT–PCR assay for
CEA frequently resulted in false negatives (Marutsuka et al, 2003)
because the expression level of the CEA mRNA was heterogeneous
in the gastric tumours which exhibited no expression of CEA
mRNA (Osaka et al, 2004), or due to the weak expression in the
non-cancerous cells, such as the mesothelial cells. CK20 also has a
relatively low specificity because of the frequent CK20 expression
in not only the cancer cells but also in the normal epithelial cells.
In our study, the sensitivity and specificity of the CEA or CK20
RT–PCR assay, which were useful for the prediction of peritoneal
recurrence were 64.9 and 82.7% or 54.6 and 80.3%, respectively.
Table 2 Relationship between peritoneal recurrence and CEA or CK20
mRNA expression
RT-PCR
Death
(n¼37)
Alive
(n¼79) P-value
Sensitivity
(%)
Specificity
(%)
CEA
Positive (n¼38) 24 14 o 0.001 64.9 82.3
Negative (n¼78) 13 65
CK 20
Positive (n¼34) 19 15 o 0.001 51.4 81.0
Negative (n¼82) 18 64
CEA and/or CK20
Positive (n¼46) 30 16 o 0.001 81.1 79.7
Negative (n¼70) 7 63
Sensitivity was defined as the positive rate for the CEA/GAPDH mRNA ratio or the
CK20/GAPDH mRNA ratio with peritoneal washes of patients who developed
recurrent peritoneal carcinomatosis. Specificity was defined as the negative rate for
the CEA/GAPDH mRNA ratio or the CK20/GAPDH mRNA ratio in patients
without any signs of peritoneal carcinomatosis.
Table 1 Relationship between the RT–PCR results, cytology and
clinicopathological findings at operation in 116 patients with gastric cancer
RT–PCR (CEA/CK20)
Clinicopathological
findings
Positive
n¼46
Negative
n¼70 P-value
Tumour depth
a
T1 or T2 7 44 o 0.001
T3 or T4 39 26
Peritoneal metastasis
Positive 12 1 o0.001
Negative 34 69
Cytology
Positive 25 2 o0.001
Negative 21 68
Stage
Io rI I 5 4 7 o0.001
III or IV 41 23
LN metastasis
Positive 40 36 o 0.001
Negative 6 34
Histological type
Intestinal type 14 33 0.073
Diffuse type 32 37
Lymphatic invasion
Positive 34 46 0.350
Negative 12 24
Venous invasion
Positive 11 14 0.616
Negative 35 56
Hepatic metastasis
Positive 5 2 0.076
Negative 41 68
aT1: tumour invades mucosa or submucosa, T2: tumour invades the muscularis
propria or the subserosa, T3: tumour penetrates the serosa and exposed to
abdominal cavity without invading the adjacent structures, T4: tumour invades the
adjacent structures. Significance level of difference was determined using Fisher’s
exact test or w
2 test.
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and 81.5%, respectively. The sensitivity of each marker was low,
but that in combination with CK20 and CEA increased (81.5%)
without any decrease in the specificity. When the cutoff value
decreases, then each marker’s sensitivity has been observed to
increase. The cutoff value in this study is appropriate because both
the sensitivity and specificity of multiple markers are high. On the
other hand, 6 of 37 of both the cytology-negative and PCR-negative
patients died as a result of peritoneal metastasis. The discovery of a
novel specific marker for gastric cancer could be expected to create
a higher accuracy for the detection of a few cancer cells in the
peritoneal lavage fluid.
It has been reported that isolated tumour cells (ITC), which
are single tumour cells or a small cell cluster (Sobin, 2003), do
not always show morphological evidence of metastatic activity,
such as peritoneal metastasis (Cserni et al, 2005). The DNA from
necrotic cancer cells may be detectable by PCR method in the
peritoneal cavity but they are nonviable and therefore their
identification at the DNA level would thus be misleading
concerning tumour progression. Our study showed that, in the
cytology-negative patients, 11 of the 17 PCR-positive patients died
due to recurrent peritoneal dissemination, and the prognosis of the
PCR-positive patients was significantly (Po0.0001) worse than
that of the PCR-negative patients. mRNA is detectable in viable
cells because RNA is unstable in necrotic cancer cells. These
findings suggest that the micrometastatic cells identified at the
RNA level by real-time quantitative RT–PCR assay are considered
to be viable for developing tumour progression for peritoneal
metastasis.
The metastatic processes that are responsible for peritoneal
dissemination remain controversial. Tumour cells originating in
the abdomen can disseminate to the mesentery in three major
0
0.2
0.4
0.6
0.8
1.0
S
u
r
v
i
v
a
l
 
r
a
t
e
S
u
r
v
i
v
a
l
 
r
a
t
e
Years after surgery
01234 5
PCR negative (n=70)
PCR positive (n=46)
PCR positive (n=15)
P< 0.0001 P< 0.0001
AB Curative R0 resection (n=80)
PCR negative (n=65)
Years after surgery
0 1234 5
0
0.2
0.4
0.6
0.8
1.0
Total (n=116)
Figure 2 The overall survival of patients based on a PCR-based analysis. The survival curve shows the Kaplan–Meier overall survival curves in relation to
the CEA and CK20 mRNA levels in the gastric carcinomas. (A) The prognosis of all 116 patients with PCR-positive tumours was significantly (Po0.001)
worse than that of those with PCR-negative tumours. (B) In the 80 patients with a curative R0 resection, the prognosis of the PCR-positive patients (n¼15)
was significantly (Po0.001) worse than that of the 65 patients who were PCR-negative.
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negative in the pT3 (A) and pT4 stages (B) The prognosis of the PCR-positive cancer was significantly poorer (P¼0.026) than that of the PCR-negative
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sways: extension via the mesenteric lymphatics, embolic haemato-
genous spread, and intraperitoneal seeding (Meyers et al, 1987;
Sheth et al, 2003; Tendo et al, 2006). In this study, the CEA and/or
CK20 examination significantly correlated with the T stage as
depth of tumour invasion (Po0.001), peritoneal dissemination
(Po0.001), whereas there was no statistically significant associa-
tion with venous invasion or lymphatic invasion. These findings
suggest that peritoneal dissemination may arise from free cancer
cells into the peritoneal cavity exfoliated mainly from the serosal
surface of the stomach penetrated by the primary tumour.
In conclusion, a real-time quantitative RT–PCR analysis of the
CEA and/or CK20 transcripts in the peritoneal lavage fluid is thus
considered to be useful for predicting the peritoneal recurrence in
patients who are undergoing a curative resection for gastric cancer.
The RT–PCR assay of peritoneal lavage might therefore be a
reliable method for the selection of patients who should undergo
therapeutic chemotherapy.
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